Home Headline News Ark Still Accumulating Novartis

#Novartis’s pipeline is deep and should give potential investors an idea of the timeline required for development of a drug for commercialization.

The company recently won a battle related to patent protection for its MS drug Gilenya. The drug generated $738 million in revenue in Q2, and the judgment protects it from generic competition through 2027.

Another reason to consider investing in pharmaceutical stocks is that they tend to pay dividends. Because Novartis is a Swiss company, it only pays an annual dividend. Depending on the jurisdiction this can be advantageous for tax purposes. 

Novartis is harnessing the advances in analytics and has developed its own platform called Nerve Live.

Short-term traders should pay closer attention to buy/sell arrows while intermediate/long-term traders should place greater emphasis on the bullish or bearish trend reflected in the lower ribbon.

Summary

Novartis is currently 7.2% above its 200-period moving average and is in an upward trend.

Volatility is low as compared to the average volatility over the last 10 periods.

Our volume indicators reflect volume flowing into and out of Novartis at a relatively equal pace (neutral).

Our trend forecasting oscillators are currently bullish on Novartis and have had this outlook for the last 7 periods.

Overall, the bias in prices is: Upwards.

A black body occurred (because prices closed lower than they opened).

During the past 10 bars, there have been 8 white candles and 2 black candles for a net of 6 white candles.

During the past 50 bars, there have been 32 white candles and 18 black candles for a net of 14 white candles.

A long upper shadow occurred.

This is typically a bearish signal (particularly when it occurs near a high price level, at resistance level, or when the security is overbought).

You may also like

logo-white

Your Trusted Source for Capital Markets & Related News

© 2024 LiveTradingNews.com – For The Traders, By The Traders – All Right Reserved.

The information contained on this website shall not be construed as (i) an offer to purchase or sell, or the solicitation of an offer to purchase or sell, any securities or services, (ii) investment, legal, business or tax advice or an offer to provide such advice, or (iii) a basis for making any investment decision. An offering may only be made upon a qualified investor’s receipt not via this website of formal materials from the Knightsbridge an offering memorandum and subscription documentation (“offering materials”). In the case of any inconsistency between the information on this website and any such offering materials, the offering materials shall control. Securities shall not be offered or sold in any jurisdiction in which such offer or sale would be unlawful unless the requirements of the applicable laws of such jurisdiction have been satisfied. Any decision to invest in securities must be based solely upon the information set forth in the applicable offering materials, which should be read carefully by qualified investors prior to investing. An investment with Knightsbridge is not suitable or desirable for all investors; investors may lose all or a portion of the capital invested. Investors may be required to bear the financial risks of an investment for an indefinite period of time. Qualified investors are urged to consult with their own legal, financial and tax advisors before making any investment. Knightsbridge is a private investment firm that offers investment services to Qualified Investors, Members and Institutions ONLY. Qualified Investors are defined as individuals who have met those Qualifications in the relevant jurisdictions. Members are defined as individuals who have been accepted into the Knightsbridge membership program. Institutions are defined as entities such as banks, pension funds, and hedge funds. If you are not a Qualified Investor, Member or Institution, you are not eligible to invest with Knightsbridge. All investments involve risk, and there is no guarantee of profit. You may lose some or all of your investment. Past performance is not indicative of future results. Knightsbridge is not a registered investment advisor, and this disclaimer should not be construed as investment advice. Please consult with a qualified financial advisor before making any investment decisions. By accessing this website, you agree to the terms of this disclaimer. Thank you for your interest in Knightsbridge.